Equity Research Analyst

Lazard is one of the world’s preeminent financial advisory and asset management firms. Our people and culture make the difference. While global in presence and reach, ours is a close, collaborative community of just over 3,000 professionals. Lazard is a place of continuous knowledge sharing, skill development and relationship building, where professionals grow and succeed together. Our entrepreneurial culture, flat structure and embrace of individual differences, allow creative ideas, original concepts, and unique perspectives to drive our business forward — and for careers to take flight.

Many of the world’s leading investors — from individuals to institutions across the globe — have entrusted Lazard Asset Management. We pride ourselves on uncovering the best investment opportunities for our clients. The purpose of our asset management business is to help our clients invest for the future — whether it’s for retirement, to grow and preserve inter-generational wealth, or to benefit the organizations that make our world smarter, healthier and more sustainable.

Lazard Asset Management is hiring an experienced US Healthcare Equity Research Analyst. 

Backed by a 175-year heritage of independent, research-driven investing, Lazard offers analysts a rare combination: the resources and global reach of a scaled platform with the intellectual latitude and collaborative culture of a boutique. For researchers who want their ideas to matter at scale — and to help shape a platform building its next chapter of growth — there has never been a more compelling moment to build a career here.

We’ll trust you to:

• Own the sector. Build and maintain a differentiated view on US pharma and biotech, including pipeline economics, patent cliffs and LOE exposure, launch trajectories, pricing and reimbursement policy, and M&A/BD capital allocation.
• Generate investable ideas. Source, underwrite, and defend long ideas with a multi-year horizon, framing the durability of growth, returns on invested capital, and the gap between market expectations and your own.
• Debate rigorously. Engage PMs and fellow analysts directly — pressure-test your thesis, challenge theirs, and update views as evidence changes. Intellectual honesty on what you got wrong matters as much as conviction on what you got right.
• Monitor positions actively. Track catalysts (clinical readouts, FDA actions, policy shifts, earnings) and communicate thesis-changing developments quickly and unambiguously.
• Maintain an expert network. Develop relationships with management teams, KOLs, physicians, payers, regulatory and policy experts, and industry consultants to source information ahead of consensus.